Per Kristian Hol
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Per Kristian Hol has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Jon Berg-Johnsen
Department of Neurosurgery, Oslo University Hospital, Oslo, Norway.
2 shared publications - Atle Bjørnerud
Division of Radiology and Nuclear Medicine Oslo University Hospital Oslo Norway
1 shared publication - Camilla Haglerød
Oxy Solutions AS, Oslo, Norway
1 shared publication - Eirik Helseth
Department of Neurosurgery, Oslo University Hospital, Oslo, Norway
1 shared publication Gregor Bachmann-Harildstad
1 shared publication- Helene Halvorsen
Department of Neurosurgery, Oslo University Hospital, Oslo, Norway.
1 shared publication
Latest Publications
- 2 January 2019
- Published by Springer Nature in Magnetic Resonance Materials in Physics, Biology and Medicine
- Vol. 32 (3) , 359-368
Precision of T1-relaxation time measurements in the hepatic portal vein: influence of measurement technique and sequence parameters
To investigate the effects of a range of parameter settings on T1 measurement stability in the portal vein using the T1-mapping sequences Look-Locker (LL) and Modified Look-Locker inversion recovery (MOLLI).
- 2 January 2019
- Published by Springer Nature in Magnetic Resonance Materials in Physics, Biology and Medicine
- Vol. 32 (3) , 359-368
Precision of T1-relaxation time measurements in the hepatic portal vein: influence of measurement technique and sequence parameters
To investigate the effects of a range of parameter settings on T1 measurement stability in the portal vein using the T1-mapping sequences Look-Locker (LL) and Modified Look-Locker inversion recovery (MOLLI).
- Open Access
- 25 October 2015
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 15 (1) , 1-9
Low immediate postoperative serum-cortisol nadir predicts the short-term, but not long-term, remission after pituitary surgery for Cushing’s disease
Cushing’s disease is an ACTH-producing pituitary adenoma, and the primary treatment is microscopic or endoscopic transsphenoidal selective adenectomy. The aims of the present study were to evaluate whether the early postoperative S-cortisol level can serve as a prognostic marker for short- and long-term remission, and retrospectively review our own short and long term results after surgery for Cushing’s disease. This single centre, retrospective study consists of 19 consecutive patients with Cushing’s disease who underwent transsphenoidal surgery. S-cortisol was measured every 6 h after the operation without any glucocorticoid replacement. We have follow-up on all patients, with a mean follow-up of 68 months. At the three-month follow-up, 16 patients (84 %) were in remission; at 12 months, 18 (95 %) were in remission and at the final follow-up (mean 68 months), 13 (68 %) were in remission. Five-years recurrence rate was 26 %. The mean postoperative S-cortisol nadir was significantly lower in the group of patients in remission than in the non-remission group at 3 months, but there was no difference between those in long-term remission compared to those in long-term non-remission. The optimal cut-off value for classifying 3-month remission was 74 nmol/l. We achieved a 95 % 1-year remission rate with transsphenoidal surgery for Cushing’s disease in this series of consecutive patients. However, the 5-year recurrence rate was 26 %, showing the need for regular clinical and biochemical controls in this patient group. The mean postoperative serum-cortisol nadir was significantly lower in patients in remission at 3 months compared to patients not in remission at 3 months, but a low postoperative S-cortisol did not predict long-term remission.
- 25 October 2015
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 15 (1) , 1-9
Open AccessLow immediate postoperative serum-cortisol nadir predicts the short-term, but not long-term, remission after pituitary surgery for Cushing’s disease
Cushing’s disease is an ACTH-producing pituitary adenoma, and the primary treatment is microscopic or endoscopic transsphenoidal selective adenectomy. The aims of the present study were to evaluate whether the early postoperative S-cortisol level can serve as a prognostic marker for short- and long-term remission, and retrospectively review our own short and long term results after surgery for Cushing’s disease. This single centre, retrospective study consists of 19 consecutive patients with Cushing’s disease who underwent transsphenoidal surgery. S-cortisol was measured every 6 h after the operation without any glucocorticoid replacement. We have follow-up on all patients, with a mean follow-up of 68 months. At the three-month follow-up, 16 patients (84 %) were in remission; at 12 months, 18 (95 %) were in remission and at the final follow-up (mean 68 months), 13 (68 %) were in remission. Five-years recurrence rate was 26 %. The mean postoperative S-cortisol nadir was significantly lower in the group of patients in remission than in the non-remission group at 3 months, but there was no difference between those in long-term remission compared to those in long-term non-remission. The optimal cut-off value for classifying 3-month remission was 74 nmol/l. We achieved a 95 % 1-year remission rate with transsphenoidal surgery for Cushing’s disease in this series of consecutive patients. However, the 5-year recurrence rate was 26 %, showing the need for regular clinical and biochemical controls in this patient group. The mean postoperative serum-cortisol nadir was significantly lower in patients in remission at 3 months compared to patients not in remission at 3 months, but a low postoperative S-cortisol did not predict long-term remission.
- 14 April 2009
- Published by Georg Thieme Verlag KG in Journal of Neurological Surgery Part B: Skull Base
- Vol. 19 (01) , A072
Endoscopic Endonasal Skull Base Surgery in a 3-T Intraoperative MRI Suite: Complications and Postoperative Hospitalization
Introduction: Endoscopic endonasal skull base surgery provides advantages including improved visualization, no need for brain retraction, and low morbidity. Patients with complex skull base lesions were selected for surgery in a multidisciplinary setting that involved neurosurgery, otorhinolaryngology, and interventional radiology. Postoperative complications and the duration of hospitalization were registered. Material and Methods: Surgery was performed in a dedicated operating suite with neuronavigation and 3 T intraoperative MRI. During the last year, we have operated on 22 patients in this setting with the following: nonproducing pituitary adenomas in 10 patients, clivus chordomas in 2, Wegener's granulomatosis in 2, recurrent CSF leak in 2, olfactory meningeoma in 1, schneiderian papilloma in 1, fibrous dysplasia in 1, petrous apex epidermoid in 1, meningoencephalocele in 1, and mucocele in 1. Results: No postoperative hematomas or infections were recorded, and none of the patients experienced deterioration of vision. In 2 patients, there was a postoperative CSF leak (9%). One of these had another surgery, and the other resolved with lumbar drainage. Postoperative hospitalization varied between 0 and 18 days, with a mean of 4.2 days and a median of 3 days. The patients who had CSF leak were both hospitalized, 1 for 18 days and the other for 12. By excluding the 2 patients with complications, the mean postoperative hospitalization was reduced to 3.1 days and the median to 2.5 days. Conclusion: Endoscopic endonasal surgery is a safe procedure for a variety of lesions at the skull base. The complications are mainly related to problems with watertight closure and skull base reconstruction, which constitute the main obstacles to further refinement of this surgery. The postoperative hospital stay is short, and the morbidity is low after endoscopic endonasal surgery.
- 14 April 2009
- Published by Georg Thieme Verlag KG in Journal of Neurological Surgery Part B: Skull Base
- Vol. 19 (01) , A072
Endoscopic Endonasal Skull Base Surgery in a 3-T Intraoperative MRI Suite: Complications and Postoperative Hospitalization
Introduction: Endoscopic endonasal skull base surgery provides advantages including improved visualization, no need for brain retraction, and low morbidity. Patients with complex skull base lesions were selected for surgery in a multidisciplinary setting that involved neurosurgery, otorhinolaryngology, and interventional radiology. Postoperative complications and the duration of hospitalization were registered. Material and Methods: Surgery was performed in a dedicated operating suite with neuronavigation and 3 T intraoperative MRI. During the last year, we have operated on 22 patients in this setting with the following: nonproducing pituitary adenomas in 10 patients, clivus chordomas in 2, Wegener's granulomatosis in 2, recurrent CSF leak in 2, olfactory meningeoma in 1, schneiderian papilloma in 1, fibrous dysplasia in 1, petrous apex epidermoid in 1, meningoencephalocele in 1, and mucocele in 1. Results: No postoperative hematomas or infections were recorded, and none of the patients experienced deterioration of vision. In 2 patients, there was a postoperative CSF leak (9%). One of these had another surgery, and the other resolved with lumbar drainage. Postoperative hospitalization varied between 0 and 18 days, with a mean of 4.2 days and a median of 3 days. The patients who had CSF leak were both hospitalized, 1 for 18 days and the other for 12. By excluding the 2 patients with complications, the mean postoperative hospitalization was reduced to 3.1 days and the median to 2.5 days. Conclusion: Endoscopic endonasal surgery is a safe procedure for a variety of lesions at the skull base. The complications are mainly related to problems with watertight closure and skull base reconstruction, which constitute the main obstacles to further refinement of this surgery. The postoperative hospital stay is short, and the morbidity is low after endoscopic endonasal surgery.